comparemela.com

Latest Breaking News On - Cingulate chairman - Page 1 : comparemela.com

FDA Clears Cingulate to File for Marketing Approval of

Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application Advancing Discussions with Commercialization Partners.

United statesKansas cityShanej schafferMatt krepsThomas daltonAnn childressDarrow associatesExchange commissionPsych congress first annual posterDrug administrationAmerican professional societyBehavior medicine incSecurities exchangePsych congressPlatform technologyCingulate inc

FDA Clears Cingulate to File for Marketing Approval of CTx-1301 in the Treatment of ADHD

Phase 3 Data Collected to Date Sufficient for Submission of New Drug Application CTx-1301 Could Benefit >60% of ADHD Patients Currently .

United statesKansas cityShanej schafferMatt krepsThomas daltonAnn childressDrug administrationBehavior medicine incPlatform technologySecurities exchangeDarrow associatesPsych congress first annual posterExchange commissionPsych congressCingulate incAmerican professional society

Peter J Werth, Successful Pharma Entrepreneur, Philanthropist, Cingulate Investor and Board

KANSAS CITY, Kan., April 30, 2024 (GLOBE NEWSWIRE) Cingulate Inc. (NASDAQ: CING), a biopharmaceutical company utilizing its proprietary Precision Timed Release™ (PTR™) drug delivery platform technology to build and

United statesKansas cityThomas daltonShanej schafferPeterj werthMatt krepsBenzinga youtubeSecurities exchangeExchange commissionChemwerth incCingulate incDarrow associatesPrecision timed releaseCingulate chairmanBenzinga all accessFriday may

Cingulate Inc (CING) Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board

Cingulate Inc (CING) Appoints Jay Roberts, Bryan Lawrence, and Jeff Ervin to its Board
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Jeff ervinJay robertsBryan lawrenceShanej schafferCingulate incCingulate chairman

Cingulate (CING) Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103

Cingulate (CING) Receives Guidance from FDA on Path Forward for Anxiety Asset CTx-2103
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesShanej schafferCingulate incDrug administrationPrecision timed releaseInvestigational new drugCingulate chairman

vimarsana © 2020. All Rights Reserved.